Enrique A Martinez

Dr. Enrique A Martinez


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
GTGonzalo Benjamin Terreros
Gonzalo Benjamin Terreros
MPMiguel Ángel Pérez
Miguel Ángel Pérez
PMPablo Muñoz-Llancao
Pablo Muñoz-Llancao
ADAmanda D’Espessailles
Amanda D’Espessailles
EMEnrique A Martinez
Enrique A Martinez
ADAlexies Dagnino-Subiabre
Alexies Dagnino-Subiabre
Brain physiology and morphology are vulnerable to chronic stress, impacting cognitive performance and behavior. However, functional compounds found in food may alleviate these alterations. White quinoa (Chenopodium quinoa, Wild) seeds contain a high content of n-3 fatty acids, including alpha-linolenic acid. This study aimed to evaluate the potential neuroprotective role of a quinoa-based functional food (QFF) in rats. Prepubertal male Sprague-Dawley rats were fed with rat chow or QFF (50% rat chow + 50% dehydrated quinoa seeds) and exposed or not to restraint stress protocol (2 h/day; 15 days). Four experimental groups were used: Non-stressed (rat chow), Non-stressed + QFF, Stressed (rat chow) and Stressed + QFF. Weight gain, locomotor activity (open field), anxiety (elevated plus maze, light-dark box), spatial memory (Y-maze), and dendritic length in the hippocampus were measured in all animals. QFF intake did not influence anxiety-like behaviors, while the memory of stressed rats fed with QFF improved compared to those fed with rat chow. Additionally, QFF intake mitigated the stress-induced dendritic atrophy in pyramidal neurons located in the CA3 area of the hippocampus. The results suggest that a quinoa-supplemented diet could play a protective role in the memory of chronically stressed rats.

28 June 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
PMPierrick Martinez
Pierrick Martinez
EMEnrique A Martinez
Enrique A Martinez
LGLionel Gillot
Lionel Gillot
WMWilliam Makis
William Makis
CPCasey Peavler
Casey Peavler
William B. GrantWilliam B. Grant
William B. Grant
Supplements are widely perceived as safe and beneficial; yet in oncology, this assumption is questionable. Clinical trials over the past few decades have often produced disappointing results, raising a critical question: are these agents used correctly, or could they inadvertently cause harm? This review examines supplements frequently used in cancer care—such as oral vitamin C, berberine, N-acetylcysteine, vitamin D, vitamin E, melatonin, polyphenols, alpha-lipoic acid, selenium, and coenzyme Q10—which can act as tumor suppressors or promoters depending on dose, route, and disease stage. We examine their dual antioxidant and pro-oxidant properties, revealing that therapeutic outcomes are shaped not only by the molecule itself, but also by bioavailability, dosing thresholds, and the tumor redox environment. Building on these insights, we propose that four factors may be considered to guide clinical use: ensure that anticancer effects are not overshadowed by antioxidant activity, achieve sufficient bioavailability, confirm pro-oxidant concentrations where possible, and prioritize supplements that target the respiration-supported non-OxPhos pathways. By framing supplements as context-dependent redox modulators rather than universally beneficial agents, this review provides a mechanistically grounded framework for informing future research and safer, more effective integrative oncology strategies.


27 June 2026 in Journal of Phycology
Verified
Journal Article
Closed access
GPGloria M. Parada
Gloria M. Parada
EMEnrique A Martinez
Enrique A Martinez
BBBernardo R. Broitman
Bernardo R. Broitman

20 May 2026 in Oxygen
Verified
Journal Article
Open access
PDF file
EMEnrique A Martinez
Enrique A Martinez
PMPierrick Martinez
Pierrick Martinez
MAManuel Aparicio-Alonso
Manuel Aparicio-Alonso
AVAntonio Vega-Galvez
Antonio Vega-Galvez
Chlorine dioxide (ClO2) is a neutral oxidant molecule with a short lifespan once in contact with electron donors (organic matter). ClO2 solutions have antiviral, antibacterial, antifungal, anti-protozoan, anti-inflammatory, anticancer, and wound-healing activity and it was used at safe concentrations on patients from different countries during the COVID-19 pandemic. In Mexico, 1067 COVID-19 patients received compassionate treatments with ClO2 during the 2020/2021 pandemic years. We describe the treatments and clinical reports of these patients, as it concerns the oxygen saturation (SpO2) recovery, and provide a biochemical explanation. The number of healed patients was 1057, >99% of the total and SpO2 showed a hyperbolic fast increase. This might happen because ClO2 attracts one electron from the organic matter and produces a chlorite anion (ClO2−). This new molecule is known to exhibit metabolic activity in the blood stream. On the one hand, it will perform the aforementioned antibiotic and healing properties. On the other hand, it will also allow the production of oxygen (O2) to be transported by the Oxyhemoglobin. This reaction is mediated by an intermediate state of a ferryl molecule (Fe=O) in the allosteric heme site of methemoglobin, which behaves as a reductase enzyme. This reaction can explain the rapid and steady increase in O2 saturation in healed patients.

2 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
EMEnrique A Martinez
Enrique A Martinez
PMPierrick Martinez
Pierrick Martinez
MAManuel Aparicio-Alonso
Manuel Aparicio-Alonso
Chlorine Dioxide (ClO2) is a neutral oxidant molecule having a short life-span once in contact with electron donors (organic matter). ClO2 solutions have antiviral, antibiotic, anti-inflammatory, anticancer and wound healing activity and it was used at safe concentrations with patients of different countries during the COVID-19 pandemic. In Mexico 1067 COVID-19 patients received compassionate treatments with ClO2 during the 2020/2021 pandemic years. We describe the treatments and clinical report of these patients, as it concerns the Oxygen saturation (SpO2) recovery and we give a biochemical explanation. The number of healed patients was 1057, >99% of the total and SpO2 showed a hyperbolic fast increase. This happens because ClO2 attracts one electron from the organic matter and produces a Chlorite anion (ClO2-). This new molecule has a known metabolic activity in the blood stream. On the one side, it will have the mentioned anti-viral, antibiotic and on the other side it will also allow producing Oxygen (O2) to be transported by the hemoglobin. This reaction is mediated by an intermediate state of a Ferryl molecule (Fe=O) in the allosteric site of methemoglobin, which behaves as a reductase enzyme. This reaction explains the rapid and steady increase of O2-saturation in healed patients.